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Background. People of the Fulani ethnic group are more resistant to malaria compared with genetically distinct
ethnic groups, such as the Dogon people, in West Africa, and studies suggest that this resistance is mediated by en-
hanced antibody responses to Plasmodium falciparum antigens. However, prior studies measured antibody respons-
es to <0.1% of P falciparum proteins, so whether the Fulani mount an enhanced and broadly reactive
immunoglobulin (Ig)M and IgG response to P falciparum remains unknown. In general, little is known about the
extent to which host genetics influence the overall antigen specificity of IgM and IgG responses to natural infections.
Methods. In a cross-sectional study in Mali, we collected plasma from asymptomatic, age-matched Fulani
(n = 24) and Dogon (n = 22) adults with or without concurrent P falciparum infection. We probed plasma against
a protein microarray containing 1087 P falciparum antigens and compared IgM and IgG profiles by ethnicity.
Results. We found that the breadth and magnitude of P falciparum-specific IgM and IgG responses were
significantly higher in the malaria-resistant Fulani versus the malaria-susceptible Dogon, and, unexpectedly,
P falciparum-specific IgM responses more strongly distinguished the 2 ethnic groups.
Conclusions. These findings point to an underappreciated role for IgM in protection from malaria, and they
suggest that host genetics may influence the antigen specificity of IgM and IgG responses to infection.
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People of the Fulani ethnic group in West Africa are at
lower risk of malaria compared with genetically distinct
ethnic groups, such as the Dogon people, who live in the
same geographic area and are exposed to similar biting
rates of Plasmodium falciparum-infected mosquitos [1].
Because of the strong selective pressure imposed by the
mortality associated with P falciparum infection in chil-
dren and pregnant women, malaria has had a signifi-
cant impact on the human genome [2]. However, the
classical red blood cell (RBC) variants associated with
protection from malaria such as hemoglobin S and C,
G6PD deficiency, and ABO blood group polymor-
phisms do not fully explain the difference in malaria
susceptibility between the Fulani and Dogon, because
these RBC variants do not appear to be enriched in
the Fulani [3].Although the mechanisms conferring en-
hanced protection against malaria in the Fulani have
yet to be precisely determined, prior studies show that
the Fulani tend to have higher levels of P falciparum-
specific immunoglobulin (Ig)M [4] and IgG [1, 4–8]
antibodies relative to levels in sympatric ethnic groups—
findings consistent with the observation that the Fulani
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have a higher percentage of activated memory B cells and
plasma cells [9]. However, studies that have compared anti-
body responses of the Fulani and sympatric ethnic groups
measured responses to either crude lysate of blood-stage para-
sites [1, 10] or a very small number of recombinant P falciparum
proteins (eg, circumsporozoite protein, thrombospondin-
related adhesive protein, and merozoite surface protein 1) [5–
7], which together comprise <0.1% of the 5000+ predicted
P falciparum proteins. This leaves open the question of whether
the Fulani generate a higher and more broadly reactive IgM and
IgG response to a wide range of P falciparum antigens—
particularly antigens to which antibody responses have been
associated with protection from malaria, as shown in other
studies [11–14].
In this study, we compared the breadth and magnitude of P
falciparum-specific IgM and IgG responses in the Fulani and
Dogon ethnic groups with a microarray containing 1087
P falciparum proteins. In particular, we investigated the extent
to which host genetic background influences the overall antigen
specificity of IgM and IgG responses to a defined pathogen.
MATERIALS AND METHODS
Study Site and Participants
This study was conducted in Mantéourou, Mali, approximately
850 km north of Bamako [1].Participants were randomly select-
ed from a cohort study described in detail elsewhere [15, 16].
Age-matched adults of the Fulani (n = 24) and Dogon
(n = 22) ethnic groups were included. As is typical in Mali, P
falciparum-infected adults had no symptoms of malaria when
blood smears were prepared. A research team, including a phy-
sician, was based in the health center at the study site. The phy-
sician conducted a medical history and physical examination at
the time of the venipuncture to determine whether signs and
symptoms of malaria or other illnesses were present. The phys-
ical examination included measurement of axillary temperature
and spleen size (graded by the Hackett score). Clinical data were
recorded on a standard case report form for each subject.
The Ethics Committee of the Faculty of Medicine, Pharmacy,
and Odonto-Stomatology at the University of Bamako, Mali ap-
proved this study. Written, informed consent was obtained
from study participants. Deidentified specimens were obtained
from this study for immunological analyses. The National Insti-
tutes of Health (NIH) Office of Human Subjects Research Pro-
tections determined that the analyses conducted at the NIH on
deidentified specimens were excluded from National Institute of
Allergy and Infectious Diseases/NIH Institutional Review
Board (IRB) review.
Plasma samples from healthy US adults were obtained
through the University of California Institute of Clinical and
Translational Science (ICTS) Normal Blood Donor program.
This program provides a source of normal human blood to
University of California investigators whose projects have
been approved by the University of California ICTS Scientific
Review Committee and the University of California IRB.
Plasma Isolation
Blood samples were drawn by venipuncture into sodium citrate-
containing cell preparation tubes (BD). Plasma was isolated
according to manufacturer’s instructions and kept frozen at
−80°C.
Measurement of Plasmodium falciparum Parasitemia
Thick blood smears were stained with Giemsa solution and
counted against 300 leukocytes. Plasmodium falciparum densi-
ties were recorded as the number of asexual parasites/µL of
blood based on an average leukocyte count of 7500/µL. Each
smear was evaluated separately by 2 expert microscopists, and
discrepancies were resolved by a third expert microscopist.
Plasmodium falciparum Protein Microarray
Protein microarrays (Antigen Discovery Inc., Irvine, CA) con-
taining 1087 sequence-verified P falciparum polypeptides were
generated using an in vitro transcription translation reaction
(RTS 100 Escherichia coli HY kits; Roche) as described previ-
ously [17]. Due to gene length, some proteins were printed on
the microarray in multiple spots of overlapping polypeptides
representing 861 unique full-length P falciparum proteins.
The protein expression efficiency of the in vitro reactions was
98.7%. The proteins included were down-selected from larger
microarray studies in which these proteins were consistently im-
munoreactive in adults living in malaria-endemic areas [18, 19].
For probing, plasma samples were (1) diluted 1:100 in Pro-
tein Array Blocking buffer (Whatman Inc, Sanford, ME) sup-
plemented with DH5α E coli lysate (MCLAB, San Francisco,
CA) at 20% (vol/vol) for IgM probing and 10% for IgG and
(2) incubated on arrays overnight at 4°C. Preabsorption with
E coli lysate is necessary to block anti-E coli antibodies [17].
Microarray slides were then incubated in biotin SP-conjugated
affinity-purified goat antihuman IgM (Fc5µ fragment-specific)
or IgG (Fcγ fragment-specific) secondary antibodies (Jackson
ImmunoResearch, West Grove, PA) and detected with streptavi-
din-conjugated SureLight P-3 (Columbia Biosciences, Columbia,
MD) both diluted 1/400 in blocking buffer without lysate. Slides
were washed and air-dried by brief centrifugation. Probed array
slides were scanned in a GenePix 4200 confocal laser scanner at a
wavelength of 670 nm, at 30% laser power and 300 and 330
photo multiplier tube for IgM and IgG, respectively. The output
gray-scale TIFF files generated by the scanner were quantitated
using ProScanArray Express software (PerkinElmer, Waltham,
MA) with spot-specific background correction.
Statistical Analysis
Protein microarray data were analyzed using the R Project for
Statistical Computing. Median foreground intensity 635 nm
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and mean background intensity 635 nm were imported sepa-
rately from 12 raw data files generated by the ProScanArray Ex-
press software. Foreground and background intensities were
log2-transformed separately. Log2 slide background noise was
subtracted from each unique spot on the array (Log2 Intensity
Ratio = Log2 median foreground–Log2 mean background).
NoDNA spots are negative controls on the array containing
the products from an empty E coli vector used to estimate
background noise and cross-reactions of antibodies to E coli
antigens. Mean log2 intensity of the NoDNA control spots
from each sample was subtracted from all the individual target
antigen fragment spots on that sample. After background sub-
traction, intensity values from all spots were normalized using
robust linear model (RLM) normalization from the robust
R package library. The RLM normalization was fit to the
NoDNA negative control spots as well as the human-IgG and
antihuman-IgG positive control spots, but the resulting normal-
ization was applied to all spots. Boxplots, histograms, density
plots, and principal component analysis plots of the data were
made for quality control assessments immediately after import
and after RLM normalization to assess the impact on any batch
effects or specific groups of spots. We separated all of the target
spots from control spots and used the mean and standard devi-
ation (SD) of the NoDNA control spots to determine which tar-
get spots were reactive. Any target spot with a log2-intensity
value greater than 2 SD around the mean of the similarly trans-
formed NoDNA spots was considered reactive. The number of
reactive antigens per subject represents each subject’s antibody
“breadth”. A negative binomial-family generalized linear model
compared the profile breadths by ethnicity. Differences in the
level or “magnitude” of antibody responses between groups
were tested using linear model comparisons of sum of the
positive log2-intensities from all antigens per sample. Tukey’s
Honest Significant Difference was used to adjust for multiple
comparisons whenever 3 or more groups were compared. Neg-
ative log2-intensities were treated as zeros. Differences in the
magnitude of antibody responses to each individual antigen
were computed using empirical Bayes moderated t test com-
parisons from the limma R package. Differences in antibody
breadth and magnitude were visualized using bee swarm scatter
plots and heat maps.
RESULTS
Subject Characteristics
Twenty-four Fulani adults and 22 age-matched Dogon adults
living in the same village in Mali were included in this study.
Demographic data and P falciparum infection status of these in-
dividuals are shown in Table 1. The median age of Fulani sub-
jects was 37 years (range: 21–57 years) and 38% were female.
The median age of Dogon subjects was 39.5 years (range: 22–
57 years) and 45% were female. At the time of blood collection,
4 Fulani (17%) and 9 Dogon (41%) were infected with P falcip-
arum by blood-smear. Of those infected, median parasite den-
sities for the Fulani and Dogon were 2375 (range: 700–3675)
and 2900 (range: 375–4725) asexual parasites/µL, respectively.
All subjects were afebrile and asymptomatic at the time of the
blood draw.
Breadth of Plasmodium falciparum-Specific Immunoglobulin
(Ig)M and IgG Response Is Higher in Fulani Versus Dogon
We first compared the breadth of P falciparum-specific IgM re-
sponses in the Fulani versus Dogon, irrespective of P falciparum
infection status. Breadth was defined for each plasma sample as
the number of antigens to which the level of IgM reactivity ex-
ceeded 2 SDs above the negative (NoDNA) control. On average,
IgM breadth was significantly higher in the Fulani (Figure 1A;
Fulani mean: 317 [SD = 283]; Dogon mean: 77 [SD = 104];
P < .001). Among uninfected subjects, IgM breadth was also sig-
nificantly higher in the Fulani (Figure 1B; Fulani mean: 280
[SD = 243]; Dogon mean: 74 [SD = 117]; P < .001); and likewise,
among infected subjects, the average IgM breadth was sig-
nificantly higher in the Fulani (Figure 1B; Fulani mean: 504
[SD = 429]; Dogon mean: 81 [SD = 89]; P = .011). Although
the difference in mean IgM breadth from infected to uninfected
subjects was larger in the Fulani (504–317 = 187 antigens) than
Dogon (81–77 = 4 antigens), this difference was not significant
(P = .75), possibly because of the small number of infected Fu-
lani subjects.
We then examined the breadth of P falciparum-specific IgG
responses for all subjects irrespective of P falciparum infection
status. The average IgG breadth was significantly higher in the
Fulani (Figure 1C; Fulani mean: 592 [SD = 253]; Dogonmean: 412
[SD = 204]; P = .014). Among uninfected subjects, IgG breadth
was higher in the Fulani, but not significantly so (Figure 1D; Fulani
mean: 603 [SD = 251]; Dogon mean: 443 [SD = 207]; P = .30), and
among infected subjects, the average IgG breadth was also higher
in the Fulani but not significantly so (Figure 1D; Fulani: 534
Table 1. Characteristics of Study Subjects by Ethnic Group
Fulani Dogon P Value
No. 24 22
Age, median in years
(range)
37 (21–57) 39.5 (22–57) .77a









2375 (700–3675) 2900 (375–4725) .59a
a Wilcoxon rank-sum test.
b Fisher’s exact test.







PI Infection Biology user on 29 June 2020
[SD = 297]; Dogon: 367 [SD = 201]; P = .58). Contrary to
what we observed for IgM, the mean IgG breadth was lower
in infected versus uninfected subjects for both the Fulani and
Dogon, although the decrease was not significant in either
case (Figure 1D). Therefore, the breadth of both IgM and IgG
P falciparum-specific responses were higher in the Fulani versus
the Dogon, but the greatest difference between the 2 groups was
in the breadth of the IgM response.
Fulani Immunoglobulin M Exclusively Recognizes a Greater
Proportion of Plasmodium falciparum Antigens
We defined IgM and IgG “recognized” antigens as those to
which the level of IgM or IgG reactivity, respectively, exceeded
2 SD above the negative control in at least 1 subject. Supple-
mentary Table 1 lists IgM- and IgG-recognized antigens. Of
999 IgM-recognized antigens, both the Fulani and Dogon
responded to 565, whereas 432 antigens were exclusively IgM-
recognized in the Fulani, and 2 antigens were exclusively
IgM-recognized in the Dogon. Eighty-eight antigens were not
IgM-recognized in any samples (Figure 2A). Of the 1070 IgG-
recognized antigens, both the Fulani and Dogon responded
to1006, whereas 54 were exclusively IgG-recognized in the Fu-
lani, and 10 exclusively IgG-recognized in the Dogon. Only 17
antigens were not IgG-recognized in any samples (Figure 2B).
Thus, the Fulani recognized most of the 1087 P falciparum an-
tigens on the protein microarray, and IgM of the Fulani bound
to a far greater number of P falciparum antigens than did those
of the Dogon (almost half of the antigens recognized by the Fu-
lani IgM samples were not recognized by the Dogon IgM sam-
ples). Although a trend to a similar difference in responsiveness
was evident in the IgG response, it was far less impressive than
that seen with IgM.
Figure 1. The breadth of Plasmodium falciparum-specific immunoglobulin (Ig)M and IgG responses is greater in the Fulani. The breadth of IgM responses
is shown for Fulani (n = 24) and Dogon (n = 22) subjects (A) and the same subjects stratified by P falciparum infection status (B). Likewise, the breadth of IgG
responses is shown for Fulani and Dogon subjects (C) and the same subjects stratified by P falciparum infection status (D). P values determined by negative
binomial family generalized linear model with log link function. Tukey’s Honest Significant Difference (HSD) was used for multiple comparison adjustments
among groups in data stratified by infection status (B and D). *P < .05; **P < .01; ***P < .001. Data are shown as means ± standard deviation.
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Magnitude of Plasmodium falciparum-Specific Immunoglobulin
(Ig)M and IgG Responses Is Higher in Fulani Versus Dogon
Next, we compared the overall level of IgM reactivity to the 1087
antigens by ethnicity irrespective of P falciparum infection sta-
tus. The sum of positive IgM log2-transformed intensity values
was significantly higher in the Fulani (Figure 3A; Fulani mean:
950 [SD = 551]; Dogon mean: 412 [SD = 265]; P = .000144).
Among uninfected subjects the sum of positive IgM log2-
intensity values was higher in uninfected Fulani versus Dogon
(Figure 3B; Fulani mean: 877 [SD = 474]; Dogon mean: 398
[SD = 286]; P = .01586). Among infected subjects, the sum of
positive IgM log2-intensity values was also higher in the Fulani
versus Dogon (Figure 3B; Fulani mean: 1317 [SD = 830]; Dogon
mean: 432 [SD = 247]; P = .0071). Although the increase in the
mean sum of IgM log2-intensity values from uninfected to in-
fected subjects was slightly larger in the Fulani (1317–877 = 440
antigens) versus Dogon (432–398 = 34 antigens), this difference
was not statistically significant (P = .361). Of note, plasma sam-
ples from healthy US adults (n = 6) had negligible IgM reactivity
(raw, untransformed intensity minus slide background) to
P falciparum antigens on the same array (US adult median:
114.9; Dogon median: 1675.0; Fulani median: 5155.9).
We then compared the level of IgG reactivity to the 1087 anti-
gens by ethnicity irrespective of infection status. The sum of pos-
itive IgG log2-transformed intensity values was higher in the
Fulani (Figure 3C; Fulani mean: 1747 [SD = 617]; Dogon mean:
1339 [SD = 488]; P = .0174). We also compared uninfected sub-
jects and found that the sum of positive IgG log2-intensity values
was higher in the uninfected Fulani versus Dogon, but this was not
significant (Figure 3D; Fulani mean: 1789 [SD = 626]; Dogon
mean: 1400 [SD = 502]; P = .22). Among infected subjects, IgG re-
activity was also higher in the Fulani, but this was not significant
(Figure 3D; Fulani mean: 1538 [SD = 603]; Dogon mean: 1252
[SD = 483]; P = .83). In contrast to IgM responses, the mean
sum of IgG log2-intensities decreased from uninfected to infected
subjects in the Fulani and Dogon. Although the decrease was
greater for the Fulani (1538–1789 =−251) versus Dogon (1252–
1400 =−148), this difference was not significant (P = .96).
Next, we compared the magnitude of IgM and IgG reactivi-
ties in the Fulani versus Dogon on an antigen-by-antigen basis
using empirical Bayes moderated t tests. Any antigen that was
not reactive (mean antigen intensity < mean + 2SD of the
NoDNA control spots) in at least 10% of all 46 samples (ie, re-
active in at least 5 samples) was removed from individual tests.
For IgM data, 697 of 1087 antigens passed the filtering process
and 667 antigens (96%) yielded statistically significant differ-
ences in IgM log2-intensity between Fulani and Dogon samples
(Figure 4A), all of which were higher in the Fulani. For IgG data,
981 of 1087 antigens passed the filtering process, but only 227
(23%) yielded statistically significant differences in IgG log2-in-
tensity between the Fulani and Dogon (Figure 4B), 97% of
which were higher in the Fulani.
We then focused on 20 antigens to which antibody levels
have been correlated with protection from malaria in studies
conducted in other malaria-endemic settings [11–14, 20, 21]
(Supplementary Table 2). Of the 19 antigens that passed the
IgM reactivity filter described above, the average level of IgM
reactivity to each antigen was significantly higher in the Fulani
after adjusting for multiple comparisons (Figure 4C). The aver-
age level of IgG reactivity was also higher in the Fulani for 17 of
20 antigens, but, in contrast to the IgM response, only 1 of these
17 was statistically significant after adjusting for multiple com-
parisons (Figure 4D). These data suggest (1) that IgM responses
play an underappreciated role in conferring resistance to malar-
ia in the Fulani and (2) that host genetics influence the overall
antigen specificity of IgM and IgG responses to malaria.
Figure 2. A higher proportion of antigens are exclusively recognized by
Fulani immunoglobulin (Ig)M. Venn diagrams showing the number of reac-
tive antigens in the Fulani and Dogon for IgM (A) and IgG (B).
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DISCUSSION
People of the Fulani ethnic group are at lower risk of malaria
compared with ethnic groups such as the Dogon people who
live in the same geographic area and are exposed to similar bit-
ing rates of P falciparum-infected mosquitos [1]. In general, IgG
is known to play a critical role in protection from blood-stage
malaria, and prior studies using small numbers of P falciparum
antigens (<0.1% of 5000+ P falciparum proteins) have shown
that the Fulani tend to have higher IgM and IgG responses
[5–7]. The question addressed here is whether the Fulani
mount a stronger and more broadly reactive IgM and IgG re-
sponse to a wide range of P falciparum antigens—particularly
antigens to which antibody responses have been associated
with protection from malaria in other studies [11–14]. In par-
ticular, we sought to better understand the extent to which host
genetics influences the overall specificity of IgM and IgG
responses to infection.
We found that Fulani adults mount a stronger and more
broadly reactive IgM and IgG response to a diverse array of P
falciparum antigens compared with Dogon adults. Moreover,
the breadth and magnitude of IgM rather than IgG responses
more strongly distinguished the Fulani and Dogon, particularly
for responses to blood-stage antigens that were previously asso-
ciated with protective antibodies [11–14]. This finding suggests
that IgM responses play an underappreciated role in protection
from malaria.
Surprisingly little is known about the role of IgM in human
malaria. The binding of nonimmune or “natural” IgM to the
surface of P falciparum-infected RBCs (iRBCs) has been impli-
cated in RBC rosetting (binding of iRBCs to uninfected RBCs)
and certain severe malaria syndromes [22–25], including
Figure 3. The overall magnitude of Plasmodium falciparum-specific immunoglobulin (Ig)M and IgG responses is greater in the Fulani. The overall mag-
nitude of IgM responses (sum of log2-intensitiy values from all antigens per sample) is shown for all Fulani and Dogon subjects (A) and the same subjects
stratified by P falciparum infection status (B). The overall magnitude of IgG responses (sum of log2-intensitiy values from all antigens per sample) is shown
for Fulani and Dogon subjects (C) and the same subjects stratified by P falciparum infection status (D). P values were determined by a linear model with
Tukey’s Honest Significant Difference (HSD) adjustments for multiple comparisons among groups in the data stratified by infection status (B and D). *P < .05;
**P < .01; ***P < .001. Data are shown as means ± standard deviation.
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placental malaria [26, 27]. The binding of nonimmune IgM to
iRBCs appears to only occur with certain P falciparum strains
[24] and is mediated through binding of a particular subset of
the parasite variant surface antigen P falciparum erythrocyte
membrane protein 1 (PfEMP1) to the Cµ4 domain of the
Fc portion of the human IgM heavy chain [23, 28, 29]. The
binding of nonimmune IgM to PfEMP1 on the surface of
iRBCs may mask protective IgG epitopes without compromis-
ing PfEMP1 function [27]. In contrast, Plasmodium-specific
IgM has been shown to limit parasite replication in mouse mod-
els of malaria [30, 31], but the role of specific IgM in human
malaria remains unclear. Our finding in this study—that the
breadth and magnitude of IgM rather than IgG responses to
P falciparum more strongly distinguish the malaria-resistant
Fulani from the susceptible Dogon—suggests that IgM may
play a more important role in protection from malaria than pre-
viously thought. This observation warrants further longitudinal
studies of the role of IgM in natural P falciparum infection, as
well as in malaria vaccine trials in the field and in the context
of controlled human malaria infection [32, 33]—particularly
since both naturally acquired and vaccine-induced immunity
to malaria tend to be short-lived in the absence of parasite
exposure [34].
The findings of this study also have implications for under-
standing how host genetic factors shape the specificity of anti-
body responses to infections. The malaria-resistant Fulani
Figure 4. Greater enhancement of immunoglobulin (Ig)M than IgG responses to individual Plasmodium falciparum antigens in the Fulani compared with
the Dogon. The average magnitude of IgM responses (log2-intensity values) to 697 individual antigens is shown for Fulani and Dogon subjects (A). The
average magnitude of IgG responses (log2-intensity) for 981 individual antigens is shown for Fulani and Dogon adults (B). Shown is the average magnitude of
IgM (C) and IgG (D) responses (log2-intensity values) for Fulani and Dogon subjects to individual antigens to which IgG levels have been correlated with
protection from malaria in other studies. For each plot, the antigens are sorted on the Dogon subjects by decreasing intensity from left to right. Dashed black
lines indicate the cutoff for statistically significant differences in antibody reactivity for individual antigens between the Fulani and Dogon. P values were
determined by empirical Bayes moderated t tests from the limma R package library with false-discovery rate adjustments for multiple tests among the
antigens. Data are shown as means.
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generated a markedly enhanced and more broadly reactive IgM
response to malaria compared with the malaria-susceptible
Dogon. There are many possible genetic changes that could
alter the malaria-specific IgM and IgG repertoires of the Fulani
and Dogon, including changes in the V gene repertoire and so-
matic hypermutation [35] as well as major histocompatibility
complex allele profiles. Another possibility is that the selective
pressure of malaria led to mutations in the Fulani that inactivat-
ed the expression of certain self-antigens that cross-react with P
falciparum antigens, allowing the Fulani to maintain B cells that
would otherwise be eliminated as autoreactive. In contrast, the
malaria-susceptible Dogon may have eliminated these autoreac-
tive but potentially protective IgM+ B cells. In support of this
hypothesis, a study in mice deficient for the UDP-galactose:β-
galactoside-α1-3-galactosyltransferase (α1,3GT) gene—which
ablates the expression of the Galα1-3Galβ1-4GlcNAc-R (α-
gal) glycan and allows for the production of anti-α-gal antibod-
ies in response to gut commensals—showed that anti-α-gal IgM
antibodies target α-gal-expressing Plasmodium sporozoites for
complement-mediated destruction in the skin after inoculation
by Anopheles mosquitoes [36]. In this context, we hypothesize
that the Fulani may have lost the ability to express certain self-
antigens that are also made by pathogens, and as a result they
can produce antibodies that other ethnic groups such as the
Dogon cannot [37, 38]. What might expand this population
of cross-reactive B cells? Although the Fulani are considered
to live sympatrically with the Dogon, the diet of the Fulani dif-
fers from that of the Dogon, and it includes high amounts of
milk and cultured milk products [39]. Such foods may shift
the composition of the gut microbiota of the Fulani [40], there-
by exposing them to commensals that drive the production of T
cell-independent IgM antibodies that cross-react with malaria
antigens.
A limitation of this study is the interpretation of antibody
breadth, defined for each sample as the number of antigens to
which IgM or IgG reactivity exceeded 2 SD above the negative
control. It is possible that IgM and IgG antibodies are present in
plasma samples at levels below this cutoff, leading to under-
estimates of breadth in some samples. Additional studies in-
volving serial dilutions of plasma samples will explore this
possibility. Another limitation is the lack of data on past P fal-
ciparum exposure. It remains possible that the higher IgM and
IgG responses of the Fulani are due to more intense and/or re-
cent P falciparum exposure. However, the Fulani and Dogon
groups were age-matched and live in sympatry in a small village,
and, moreover, IgM and IgG responses were higher in the un-
infected Fulani compared with the infected Dogon. It is possible
that blood smear-negative subjects harbored subpatent P falcip-
arum infection (polymerase chain reaction [PCR] positive).
Unfortunately, only blood smears and plasma were available
from these archived samples so PCR was not done. However,
the breadth and magnitude of IgM and IgG responses tended
to be higher in the blood smear-negative Fulani compared
with the blood smear-positive Dogon; therefore, even if the
blood smear-negative Fulani were PCR+ (subpatent parasite-
mia), their antibody responses were higher than the blood
smear-positive Dogon who presumably had higher (patent)
parasitemias.
CONCLUSIONS
In summary, we found that IgM and IgG responses to P falcipa-
rum are enhanced and more broadly reactive in the malaria-
resistant Fulani compared with the malaria-susceptible Dogon,
and, unexpectedly, the breadth and magnitude of the IgM re-
sponse more strongly distinguished these 2 ethnic groups.
These findings suggest that IgM may play an underappreciated
role in protection from malaria, and they also raise the intriguing
possibility that the selective pressure of malaria has resulted in
host genetic polymorphisms that yield more robust and protective
IgM responses in certain ethnic groups.
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